Matches in Wikidata for { <http://www.wikidata.org/entity/Q82849742> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q82849742 description "article scientifique (publié 2011)" @default.
- Q82849742 description "artikull shkencor i botuar më 01 janar 2011" @default.
- Q82849742 description "artículu científicu espublizáu en xineru de 2011" @default.
- Q82849742 description "im Januar 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82849742 description "scientific article published on 01 January 2011" @default.
- Q82849742 description "wetenschappelijk artikel" @default.
- Q82849742 description "наукова стаття, опублікована в січні 2011" @default.
- Q82849742 name "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 name "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 name "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 type Item @default.
- Q82849742 label "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 label "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 label "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 prefLabel "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 prefLabel "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 prefLabel "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 P1433 Q82849742-95A35F2C-6430-446A-9BD5-F8E9A358C120 @default.
- Q82849742 P1476 Q82849742-710BA532-3C6D-4859-93AA-F4737CCF7A4C @default.
- Q82849742 P2093 Q82849742-1FF7D770-D2DA-48B6-98BD-32A2BCA19D89 @default.
- Q82849742 P2093 Q82849742-59E0D3F2-08B9-40FE-899F-E83868C6A0F4 @default.
- Q82849742 P2093 Q82849742-5B882F8E-9001-47C3-8568-458FCD1A3005 @default.
- Q82849742 P2093 Q82849742-98CB600E-A62B-4F66-A8B5-D9C7FBAF23EF @default.
- Q82849742 P2093 Q82849742-9E5BFEE6-B2D8-4EAF-96C5-1E2D1B08F88D @default.
- Q82849742 P2093 Q82849742-A98B5B5E-5BFB-45D0-BE7F-46B2DFA06715 @default.
- Q82849742 P2093 Q82849742-CE81A330-C9D5-42F4-9F5D-F9A84C5847FD @default.
- Q82849742 P2093 Q82849742-D451E743-86B9-407A-AA46-F79EADF9ADF9 @default.
- Q82849742 P2093 Q82849742-F29783C9-7629-441B-B11C-71F0A8EE609B @default.
- Q82849742 P304 Q82849742-5125A3CB-88A5-4E80-9BC4-CE9B500BB668 @default.
- Q82849742 P31 Q82849742-0520AC72-D53F-4F11-9592-C9048C9D7CD7 @default.
- Q82849742 P356 Q82849742-55187BD2-2D78-4A58-84FF-BDD239165825 @default.
- Q82849742 P433 Q82849742-3F008974-B938-4197-81C6-E95312676546 @default.
- Q82849742 P478 Q82849742-524E3985-5CE6-4B5C-A4E1-2676E248989C @default.
- Q82849742 P50 Q82849742-78637AE0-2CA0-4B5D-A9FC-1FC63D88DACF @default.
- Q82849742 P577 Q82849742-BFEAB9BA-08C3-4B3A-A0E3-A8B543954817 @default.
- Q82849742 P698 Q82849742-12F6BB25-3DAA-4B7C-85D2-1C2AD5E03A6B @default.
- Q82849742 P921 Q82849742-ACAF2131-D839-481F-8B9E-AC33F1514F5E @default.
- Q82849742 P356 QAD.0B013E3283416873 @default.
- Q82849742 P698 21150563 @default.
- Q82849742 P1433 Q4651863 @default.
- Q82849742 P1476 "A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population" @default.
- Q82849742 P2093 "Andrew Hill" @default.
- Q82849742 P2093 "Brian Gazzard" @default.
- Q82849742 P2093 "Daniel Podzamczer" @default.
- Q82849742 P2093 "Dénes Banhegyi" @default.
- Q82849742 P2093 "Hans-Jürgen Stellbrink" @default.
- Q82849742 P2093 "Johan Vingerhoets" @default.
- Q82849742 P2093 "Mark Nelson" @default.
- Q82849742 P2093 "Stephan Marks" @default.
- Q82849742 P2093 "Thomas Stark" @default.
- Q82849742 P304 "335-340" @default.
- Q82849742 P31 Q13442814 @default.
- Q82849742 P356 "10.1097/QAD.0B013E3283416873" @default.
- Q82849742 P433 "3" @default.
- Q82849742 P478 "25" @default.
- Q82849742 P50 Q58888627 @default.
- Q82849742 P577 "2011-01-01T00:00:00Z" @default.
- Q82849742 P698 "21150563" @default.
- Q82849742 P921 Q422645 @default.